FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
This Quarter Return
+4.73%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$306M
AUM Growth
+$306M
(+17%)
Cap. Flow
+$57.6M
Cap. Flow
% of AUM
18.82%
Top 10 Holdings %
Top 10 Hldgs %
85.78%
Holding
34
New
9
Increased
9
Reduced
4
Closed
8
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$18.6M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$15.6M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$10.1M |
| 4 |
Forte Biosciences
FBRX
|
$9.06M |
| 5 |
VRNA
Verona Pharma
VRNA
|
$7.15M |
Top Sells
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$5.75M |
| 2 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$5.43M |
| 3 |
Protagonist Therapeutics
PTGX
|
$4.44M |
| 4 |
Aclaris Therapeutics
ACRS
|
$4.18M |
| 5 |
iRhythm Technologies
IRTC
|
$2.63M |
Sector Composition
| 1 | Healthcare | 44.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
1
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $102M | 33.48% | 1,950,477 +353,776 | +22% | +$18.6M |
|
|
AKAO
2
DELISTED
Achaogen, Inc.
AKAO
| $27.2M | 8.87% | 1,250,000 +4,813 | +0.4% | +$105K |
|
|
ALDR
3
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $24.9M | 8.14% | 2,177,203 +547,981 | +34% | +$6.27M |
|
|
BPMC
4
DELISTED
Blueprint Medicines
BPMC
| $23.3M | 7.61% | 460,000 +199,600 | +77% | +$10.1M |
|
|
AIMT
5
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $18.8M | 6.13% | 912,001 | – | – |
|
6
Wave Life Sciences
WVE
$1.53B
| $18.7M | 6.1% | 1,004,100 +327,972 | +49% | +$6.1M |
|
|
IMMU
7
DELISTED
Immunomedics Inc
IMMU
| $17.1M | 5.6% | 1,940,850 +1,767,979 | +1,023% | +$15.6M |
|
|
EPZM
8
DELISTED
Epizyme, Inc
EPZM
| $12.1M | 3.94% | 799,363 +117,441 | +17% | +$1.77M |
|
|
9
Forte Biosciences
FBRX
$137M
| $9.06M | 2.96% | +753,000 | New | +$9.06M |
|
|
LOXO
10
DELISTED
Loxo Oncology, Inc
LOXO
| $9.02M | 2.95% | 112,500 +12,500 | +13% | +$1M |
|
11
FibroGen
FGEN
$47.8M
| $8.08M | 2.64% | 250,000 +162,016 | +184% | +$5.23M |
|
|
VRNA
12
Verona Pharma
VRNA
$9.16B
| $7.15M | 2.34% | +613,601 | New | +$7.15M |
|
|
BLCM
13
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $5.29M | 1.73% | 452,727 -465,273 | -51% | -$5.43M |
|
|
DERM
14
DELISTED
Dermira, Inc.
DERM
| $5.14M | 1.68% | 176,211 | – | – |
|
15
Pacific Biosciences
PACB
$393M
| $4.45M | 1.45% | +1,250,000 | New | +$4.45M |
|
16
argenx
ARGX
$43.6B
| $3.74M | 1.22% | +176,500 | New | +$3.74M |
|
|
NSTG
17
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.96M | 0.97% | 178,681 -139,905 | -44% | -$2.31M |
|
18
Sangamo Therapeutics
SGMO
$157M
| $1.36M | 0.44% | +154,000 | New | +$1.36M |
|
|
INFI
19
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.16M | 0.38% | +738,896 | New | +$1.16M |
|
|
OREX
20
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.1M | 0.36% | 380,530 | – | – |
|
21
Larimar Therapeutics
LRMR
$310M
| $822K | 0.27% | 234,092 -136,784 | -37% | -$480K |
|
|
BHVN
22
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $750K | 0.25% | +30,000 | New | +$750K |
|
23
Ascendis Pharma
ASND
$11.8B
| $622K | 0.2% | 22,400 -77,600 | -78% | -$2.15M |
|
|
XLRN
24
DELISTED
Acceleron Pharma Inc.
XLRN
| $604K | 0.2% | 19,886 | – | – |
|
25
Ardelyx
ARDX
$1.53B
| $191K | 0.06% | +37,500 | New | +$191K |
|